ChAdOx1 nCoV-19 Vaccine Safe and Immunogenic in Individuals With HIV
A team of investigators sought to characterize immune responses to vaccination
against SARS-CoV-2 in people with HIV.
All articles by Bradley van Paridon
COVID-19 Outcomes Assessed Among Patients With Autoimmune Inflammatory Rheumatic Diseases in South Korea
Researchers conducted a nationwide cohort study to determine the association between autoimmune inflammatory rheumatic diseases and COVID-19 in South Korea, early in the pandemic.
Frequency, Variety, and Severity of Persistent COVID-19 Symptoms
Researchers systematically reviewed studies to gauge the frequency, variety, and severity of persistent symptoms after COVID-19 infection.
Guidelines to Reduce Empiric Antibiotic Therapy Among Inpatients With COVID-19
Investigators conducted a quasi-experimental, retrospective study of adult patients with COVID-19 pneumonia to evaluate antibiotic use for community-acquired bacterial pneumonia following the release of guidelines.
No Detectable Association Between mRNA COVID-19 Vaccines and Facial Paralysis
While several cases of facial paralysis were observed during the phase 3 clinical trials of the mRNA COVID-19 vaccine, a causal relationship could not be established. With the US Food and Drug Administration recommending monitoring of vaccine recipients, the researchers looked at a disproportionality analysis using the WHO’s pharmacovigilance database, VigiBase.
Predictors of Failed Pseudomonas aeruginosa Eradication in Children With Cystic Fibrosis
Investigators sought to determine whether resistance to antibiotic treatment was associated with failed eradication therapy in patients with cystic fibrosis.
COVID-19 Death Rates and Risk Perception Led to More Time Spent At Home
Investigators collected survey data on demographics, risk perception, and death rate to assess their impact on voluntary behaviors, such as time spent at home.
Definitive and Indeterminate Pseudomonas aeruginosa Pneumonia Among Patients With CAP
A team of investigators sought to determine the prevalence of definitive and
indeterminate Pseudomonas aeruginosa pneumonia among patients with CAP.
Ivermectin Therapy Not Efficacious in Patients With Mild COVID-19
Investigators selected patients with mild COVID-19 to receive either ivermectin or placebo to determine whether ivermectin is an efficacious treatment.
Repeated Influenza Vaccination Could Reduce Effectiveness
Researchers assessed the impact on pooled adjusted end-season vaccine effectiveness estimates from outpatient test-negative design studies.
- Loading...
Loading...
Next post in Influenza
Loading... 
Loading...